Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNIX-HF
NCT05562167Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Mar 2023
- Primary completion
- May 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of potassium nitrate in heart failure with reduced ejection fraction (HFrEF) (2 arms), sponsored by Washington University School of Medicine. Primary endpoints: Peak Oxygen Uptake and Maximal muscle power. Started Mar 2023; status: recruiting.
02
Drugs
potassium nitrate
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT05562167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05562167.